Welcure Drugs Financials

BSE: 524661

₹0.25

₹0.01 (4.17%)

As on 03-Sep-2026 13:35IST

Market cap

₹28 Cr

Revenue (TTM)

₹366 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	365.54	24.55	--	--	0.11	0.13
Total Income	367.00	26.46	0.09	0.24	0.11	0.13
Total Expenditure	372.92	23.58	0.23	0.13	0.08	0.08
EBITDA	-7.38	0.97	-0.23	-0.13	0.02	0.06
Depreciation	0.02	0.01	0.04	0.00	--	--
EBIT	-7.40	0.96	-0.27	-0.14	0.02	0.06
Interest	--	0.09	0.00	--	0.00	0.00
Other Income	1.46	1.91	0.09	0.24	--	0.00
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-5.93	2.78	-0.17	0.10	0.02	0.06
Provision for Tax	11.06	0.61	--	--	--	--
Profit after Tax	-16.99	2.17	-0.17	0.10	0.02	0.06

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	134.32	102.51	1.34	1.52	0.09	0.07
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	123.20	123.20	--	--	--	--
Current Liabilities	375.38	41.27	0.03	0.01	0.00	0.00
Total Liabilities	632.89	266.98	1.37	1.53	0.10	0.07

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	84.75	84.84	1.34	1.52	0.03	--
Current Assets	548.05	182.14	0.03	0.01	0.07	0.07
Total Assets	632.89	266.98	1.37	1.53	0.10	0.07
Total Debt*	--	123.20	--	--	--	--
Net Current Assets	172.67	140.87	0.00	-0.01	0.06	0.07
Contingent Liabilities	--	--	--	0.33	0.33	0.33

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-222.03	-0.13	0.11	0.02	0.04
Cash Flow from Investing Activities	--	-0.06	0.17	--	--	--
Cash from Financing Activities	--	222.20	-0.02	-0.17	--	--
Net Cash Inflow / Outflow	--	0.11	0.02	-0.07	0.02	0.04

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	1.75	0.02	-0.01	0.01	0.00	0.00
Cash EPS (₹)	-0.04	0.02	-0.01	0.01	0.00	0.00
Adjusted Book Value (₹)	0.78	0.83	0.09	0.10	0.01	0.01
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-19.75	-0.09	0.08	0.02	0.03
Free Cash Flow per Share (₹)	--	-19.80	-0.09	0.08	0.02	0.03

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	2.53	-12.24	12.69	29.12	131.94
ROE (%)	-14.35	4.18	-12.24	12.69	29.03	131.74
ROA (%)	-3.76	1.62	-12.06	12.55	27.77	112.99
EBIT Margin (%)	-2.02	3.91	--	--	22.52	41.26
Net Margin (%)	-4.63	8.20	-186.16	43.04	22.46	41.29
Cash Profit Margin (%)	0.00	8.87	--	--	22.46	41.36

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	569.50	--	--	-100.00	-21.26	61.63
EBIT Growth (%)	-343.60	457.30	-98.96	-670.88	-57.02	673.10
Net Profit Growth (%)	-481.86	1,341.48	-271.37	332.58	-57.24	686.68
EPS Growth (%)	-159.68	248.31	-271.02	289.23	-57.14	683.33
Book Value Growth (%)	--	7,547.19	-11.52	1,528.98	33.96	385.48

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	0.14	4.28	--	52.97	501.03	41.32
Price / Book Value	0.29	1.00	3.77	3.57	127.31	32.82
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-27.92	78.30	-36.25	51.44	497.89	40.39
Close Price (₹)	0.24	0.83	0.34	0.37	0.89	0.17
High Price (₹)	1.44	1.44	0.50	1.05	1.10	0.21
Low Price (₹)	0.24	0.35	0.29	0.33	0.17	0.04
Market Cap (₹ Cr)	28.43	102.21	--	--	11.84	2.28

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.92	1.20	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.46	4.41	1.05	0.43	17.30	20.33
Quick Ratio	1.08	0.94	1.05	0.43	17.30	20.33
Interest Coverage	--	32.06	-1,747.00	--	346.74	636.34

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	105.18	77.19	--	--	--	--
Asset Turnover	0.81	0.18	--	--	1.24	2.73
Receivable days	--	281.74	--	--	--	--
Inventory Days	--	2,133.85	--	--	--	--
Payable days	--	51.58	--	--	--	--
Cash Conversion Cycle	--	2,364.01	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.